Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of PELI2 deficiency on the gene expression of bone marrow B220+ cells

ABSTRACT: To investigate the effect of PELI2 in the regulation of bone marrow B220+ cells in PELI2 knockout mice. We then performed gene expression profiling analysis using data obtained from RNA-seq of 2 different cells.

ORGANISM(S): Mus musculus

PROVIDER: GSE228984 | GEO | 2024/03/27

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Effect of PELI2 deficiency on the gene expression of bone marrow B220+ cells

Project description:Effect of PELI2 deficiency on the gene expression of bone marrow B220+ cells

| PRJNA952312 | ENA

Single-cell analysis of bone marrow B220+ cells from 56R and LAPTM5 knockout (LAPTM5KO) 56R mice

Project description:Single-cell analysis of bone marrow B220+ cells from 56R and LAPTM5 knockout (LAPTM5KO) 56R mice

| PRJNA822099 | ENA

RNAseq of pro-B cells and CD19+B220- cells in the bone marrow of WT and PAX5 Y351*/351* mice

Project description:Gene expression profiling of pro-B cells in the bone marrow of WT and PAX5<Y351*/Y351*> mice and also of CD19+B220- cells found only in the BM of PAX5<Y351*/Y351*> mice. We used a modified single-cell protocol (4 wells of 50 cells each per sample) and then combined all data from the same sample for the analysis.

2023-04-01 | E-MTAB-11241 | biostudies-arrayexpress

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Project description:RATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of bone marrow transplantation in treating patients who have hematologic cancer.

| 2004880 | ecrin-mdr-crc

Effect of deficiency of Siglec-15 during osteoclast differentiation of murine bone marrow macrophages

Project description:To investigate the function of Siglec-15 in the regulation of osteoclast differentiation, Siglec-15 deficient mice was established. Then gene expression profiling analysis using data obtained from RNA-seq of bone marrow macrophages with M-CSF and RANKL at two different time points was performed.

2023-12-01 | GSE218768 | GEO

Bone marrow niche

Project description:Bone marrow niche

| PRJNA429031 | ENA

scRNAseq for bone marrow cells from Cebpαcre/+ R26EYFP/+ SbdsF/F (neutropenia) mice vs Cebpαcre/+ R26EYFP/+ Sbds+/+ (Ctrl) mice

Project description:To delineate the potential molecular mechanisms underlying the communication between neutrophils and NK cells, we performed scRNAseq of the neutropenic bone marrow (12 months after transplantation of Cebpacre/+ Sbds +/+ or F/F cells). To this end, bone marrow cells were subsorted into HSC+MPP (LKS CD48-), HPC1 (LKS CD48+CD150-), B and T cells (B220+, CD3+), NK cells (NK1.1+ NKp46+) and a myeloid ‘rest’ fraction (B220-,CD3-,NKp46- and NK1.1-) and sorted fractions pooled together to obtain robust representation of all bone marrow cell types in the scRNAseq data

2022-12-31 | E-MTAB-12428 | biostudies-arrayexpress

Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer

Project description:This phase II trial studies how well giving fludarabine phosphate, cyclophosphamide, tacrolimus, mycophenolate mofetil and total-body irradiation together with a donor bone marrow transplant works in treating patients with high-risk hematologic cancer. Giving low doses of chemotherapy, such as fludarabine phosphate and cyclophosphamide, and total-body irradiation before a donor bone marrow transplant helps stop the growth of cancer cells by stopping them from dividing or killing them. Giving cyclophosphamide after transplant may also stop the patient’s immune system from rejecting the donor’s bone marrow stem cells. The donated stem cells may replace the patient’s immune system cells and help destroy any remaining cancer cells (graft-versus-tumor effect). Sometimes the transplanted cells from a donor can also make an immune response against the body’s normal cells. Giving tacrolimus and mycophenolate mofetil after the transplant may stop this from happening

| 2008483 | ecrin-mdr-crc

bone marrow metagenome

Project description:Rashidi - 7D Bone Marrow

| PRJNA698990 | ENA

Murine bone marrow immature B cells: autoreactive versus non-autoreactive

Project description:Transcriptional profiling of mouse bone marrow B220+CD23–CD43–IgD– autoreactive immature B cells from 3-83Igi,Rag1-/-,H-2b mice relative to non-autoreactive immature B cells from 3-83Igi,H-2d mice. Goal was to determine genes that potentially mediate negative and positive selection of immature B cells.

2010-08-31 | GSE22802 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data